Skip to main content

Table 1 Resistance to cefixime, azithromycin and ciprofloxacin in N. gonorrhoeae isolates from 24 EU/EEA countries, 2015

From: Overall Low Extended-Spectrum Cephalosporin Resistance but high Azithromycin Resistance in Neisseria gonorrhoeae in 24 European Countries, 2015

Country

No. of isolates tested

Resistance

Method of testing

Cefixime

Azithromycin

Ciprofloxacin

No.

%

No.

%

No.

%

Austria

61

0

0.0%

2

3.3%

40

65.6%

Decentralised – Etest

Belgium

99

11

11.1%

3

3.0%

49

49.5%

Decentralised – AD

Croatia

8

0

0.0%

0

0.0%

3

37.5%

Centralised – Etest

Cyprus

3

0

0.0%

0

0.0%

2

66.7%

Decentralised – Etest

Denmark

110

0

0.0%

3

2.7%

34

30.9%

Decentralised – Etest

Estonia

18

0

0.0%

0

0.0%

5

27.8%

Centralised – Etest

France

105

0

0.0%

6

5.7%

44

41.9%

Decentralised – Etest

Germany

109

2

1.8%

2

1.8%

67

61.5%

Centralised – BKP/Etest

Greecea

100

11

11.0%

22

22.0%

77

77.0%

Decentralised – Etest

Hungary

64

1

1.6%

3

4.7%

34

53.1%

Centralised - BKP/Etest

Iceland

14

0

0.0%

0

0.0%

4

28.6%

Decentralised – Etest

Ireland

110

1

0.9%

20

18.2%

50

45.5%

Decentralised – Etest

Italy

100

0

0.0%

2

2.0%

71

71.0%

Decentralised – Etest

Latvia

9

0

0.0%

0

0.0%

1

11.1%

Centralised – Etest

Malta

29

0

0.0%

4

13.8%

19

65.5%

Decentralised – Etest

Netherlands

200

0

0.0%

8

4.0%

74

37.0%

Decentralised – Etest

Norway

110

1

0.9%

4

3.6%

64

58.7%b

Decentralised – AD

Poland

56

0

0.0%

3

5.4%

32

57.1%

Centralised – Etest

Portugal

110

0

0.0%

19

17.3%

41

37.3%

Decentralised – Etest

Slovakia

104

4

3.8%

2

1.9%

56

53.8%

Centralised – Etest

Slovenia

109

0

0.0%

0

0.0%

38

34.9%

Decentralised – Etest

Spain

167

4

2.4%

5

3.0%

109

65.3%

Decentralised – Etest

Sweden

100

0

0.0%

14

14.0%

45

45.0%

Decentralised – Etest

UK

239

1

0.4%

30

12.6%

95

39.7%

Decentralised – AD/Etest

Total:

        

Cefixime

2132

36

1.7%

     

Ciprofloxacin

2133

    

1054

49.4%

 

Azithromycin

2134

  

152

7.1%

   

95% CI

  

1.2–2.3

 

6.1–8.3

 

47.3–51.5

 
  1. EU/EEA European Union/European Economic Area, No. Number, Etest minimum inhibitory concentration (MIC) gradient strips to determine the MIC of an antimicrobial (mostly Etests, but also some other MIC gradient strips were used in some countries), AD agar dilution method to determine the MIC of an antimicrobial, BKP Breakpoint agar dilution method, CI confidence interval of the mean %
  2. aOnly one (0.05%) ceftriaxone resistant isolate was identified in Euro-GASP in 2015 (in Greece; MIC = 0.25 mg/L)
  3. bCalculated from 109 isolates with ciprofloxacin results